These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Rothbard RL Drugs; 1987; 33 Suppl 3():276-8. PubMed ID: 3315606 [TBL] [Abstract][Full Text] [Related]
3. Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study. Monassier JP; Hanssen M Drugs; 1987; 33 Suppl 3():282-5. PubMed ID: 3315608 [TBL] [Abstract][Full Text] [Related]
4. Assessment of left ventricular function in a randomised study of intravenous anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Preliminary results of the European Multicentre Study (Belgian Centres). Taeymans Y; Materne P Drugs; 1987; 33 Suppl 3():216-20. PubMed ID: 3315594 [TBL] [Abstract][Full Text] [Related]
5. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Efficacy data. Chamberlain DA Drugs; 1987; 33 Suppl 3():221-2. PubMed ID: 3315596 [No Abstract] [Full Text] [Related]
6. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States. Anderson JL Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584 [TBL] [Abstract][Full Text] [Related]
7. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study. Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerance data from the Belgian multicentre study of anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Bossaert LL Drugs; 1987; 33 Suppl 3():287-92. PubMed ID: 3315610 [TBL] [Abstract][Full Text] [Related]
9. Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin. Croydon EA Drugs; 1987; 33 Suppl 3():293-6. PubMed ID: 3315611 [TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled patency study of intravenous anisoylated plasminogen streptokinase activator complex 30U in acute myocardial infarction. de Bono DP Drugs; 1987; 33 Suppl 3():138-9. PubMed ID: 3315580 [No Abstract] [Full Text] [Related]
15. AIMS. The design and conduct of a multicentre mortality study comparing placebo and anisoylated plasminogen streptokinase activator complex 30 units intravenously for the treatment of acute myocardial infarction of less than 6 hours duration. UK APSAC Advisory Committee. Drugs; 1987; 33 Suppl 3():227-8. PubMed ID: 3315598 [No Abstract] [Full Text] [Related]
16. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy and safety of anisoylated plasminogen streptokinase activator complex in early myocardial infarction. Preliminary results. Lenhoff SJ; Horak AR; Fraser RC; Scott-Millar RN; Bird AR; Jacobs P; Commerford PJ Drugs; 1987; 33 Suppl 3():186-8. PubMed ID: 3315590 [No Abstract] [Full Text] [Related]
18. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. Meinertz T; Kasper W; Schumacher M; Just H Am J Cardiol; 1988 Sep; 62(7):347-51. PubMed ID: 3046283 [TBL] [Abstract][Full Text] [Related]
19. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction. Rothbard RL; Anderson JL; Fitzpatrick PG; Hakworthy RA; Sorensen SG; Marder VJ Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234 [TBL] [Abstract][Full Text] [Related]
20. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]